A critical literature review of health economic evaluations in pertussis booster vaccination
Authors:
- Samuel AballeaSASamuel Aballea
- Lieven AnnemansLALieven Annemans
- Mondher ToumiMTMondher Toumi
- Sibilia QuiliciSQSibilia Quilici
- 1 February 2012
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 12 (1) , 71-94
Abstract
A review of worldwide economic evaluations of pertussis booster vaccination for adolescents and adults was conducted. Thirteen cost-effectiveness, cost-utility and economic impact models were identified. The most frequently studied strategies were adolescent booster, one-time adult booster, adult decennial boosters and cocoon strategy. All studies evaluating adolescent booster suggested this was a cost-effective or cost-saving strategy compared with no booster vaccination. Conclusions concerning adult vaccination, alone or in combination with adolescent vaccination, vary between studies. Studies were often strongly affected by assumptions regarding the amount of unreported cases and lack of reliable input data on real incidence, other epidemiological inputs, costs associated with mild disease and herd immunity effects. Reviewed studies were generally in favor of pertussis booster vaccination, but did not identify any optimal vaccination strategy. Future economic evaluations should explore a wider range of strategies, taking into account country-specific considerations.Keywords
This publication has 30 references indexed in Scilit:
- Rationale for pertussis booster vaccination throughout life in EuropeThe Lancet Infectious Diseases, 2011
- Modelling the Epidemiology of Infectious Diseases for Decision AnalysisPharmacoEconomics, 2011
- Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failureProceedings of the National Academy of Sciences, 2011
- Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic ModelPLOS ONE, 2010
- Global, regional, and national causes of child mortality in 2008: a systematic analysisThe Lancet, 2010
- Adult Vaccination Strategies for the Control of Pertussis in the United States: An Economic Evaluation Including the Dynamic Population EffectsPLOS ONE, 2009
- Cost Effectiveness of Pertussis Vaccination in AdultsAmerican Journal of Preventive Medicine, 2007
- Economic Evaluation of an Extended Acellular Pertussis Vaccine Program for Adolescents in Qu??bec, CanadaPediatric Drugs, 2005
- Evaluation of Strategies for Use of Acellular Pertussis Vaccine in Adolescents and Adults: A Cost-Benefit AnalysisClinical Infectious Diseases, 2004
- The Decision Rules of Cost-Effectiveness AnalysisPharmacoEconomics, 1996